Michael R Megna - Net Worth and Insider Trading

Michael R Megna Net Worth

The estimated net worth of Michael R Megna is at least $314,473 dollars as of 2024-04-27. Michael R Megna is the CHIEF ACCOUNTING OFFICER of Kiniksa Pharmaceuticals Ltd and owns about 17,588 shares of Kiniksa Pharmaceuticals Ltd (KNSA) stock worth over $314,473. Details can be seen in Michael R Megna's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael R Megna has not made any transactions after 2024-03-01 and currently still holds the listed stock(s).

Transaction Summary of Michael R Megna

To

Michael R Megna Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael R Megna owns 1 companies in total, including Kiniksa Pharmaceuticals Ltd (KNSA) .

Click here to see the complete history of Michael R Megna’s form 4 insider trades.

Insider Ownership Summary of Michael R Megna

Ticker Comapny Transaction Date Type of Owner
KNSA Kiniksa Pharmaceuticals Ltd 2024-03-01 Chief Accounting Officer

Michael R Megna Latest Holdings Summary

Michael R Megna currently owns a total of 1 stock. Michael R Megna owns 17,588 shares of Kiniksa Pharmaceuticals Ltd (KNSA) as of March 1, 2024, with a value of $314,473.

Latest Holdings of Michael R Megna

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KNSA Kiniksa Pharmaceuticals Ltd 2024-03-01 17,588 17.88 314,473

Holding Weightings of Michael R Megna


Michael R Megna Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael R Megna has made a total of 2 transactions in Kiniksa Pharmaceuticals Ltd (KNSA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Kiniksa Pharmaceuticals Ltd is the sale of 14,785 shares on March 1, 2024, which brought Michael R Megna around $318,912.

Insider Trading History of Michael R Megna

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael R Megna Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael R Megna Ownership Network

Ownership Network List of Michael R Megna

No Data

Ownership Network Relation of Michael R Megna


Michael R Megna Owned Company Details

What does Kiniksa Pharmaceuticals Ltd do?

Who are the key executives at Kiniksa Pharmaceuticals Ltd?

Michael R Megna is the Chief Accounting Officer of Kiniksa Pharmaceuticals Ltd. Other key executives at Kiniksa Pharmaceuticals Ltd include director & 10 percent owner & Chairman & CEO Sanj K Patel , Chief Medical Officer John Paolini , and Chief Business Officer Eben Tessari .

Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trades Summary

Over the past 18 months, Michael R Megna made 2 insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA) with a net sale of 24,101. Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 96,513 shares made by John Paolini , a net sale of 83,336 shares made by Sanj K Patel , and a net sale of 21,959 shares made by Barry D Quart .

In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 225,909 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,909 shares.

Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kiniksa Pharmaceuticals Ltd Insider Transactions

No Available Data

Michael R Megna Mailing Address

Above is the net worth, insider trading, and ownership report for Michael R Megna. You might contact Michael R Megna via mailing address: 1050 Hingham Street, Rockland Ma 02370.

Discussions on Michael R Megna

No discussions yet.